US2022098652A1PendingUtilityA1
Nicking and extension amplification reaction (near) of streptococcus species
Est. expiryDec 28, 2035(~9.5 yrs left)· nominal 20-yr term from priority
C12Q 1/6844C12Q 2600/158
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to compositions, methods and kits for detecting the presence or absence of a bacterial species in a biological sample using isothermal nucleic acid amplification.
Claims
exact text as granted — not AI-modified1 .- 47 . (canceled)
48 . A composition comprising:
a forward template comprising a nucleic acid sequence comprising a recognition region at the 3′ end that is complementary to the 3′ end of the Streptococcus pyogenes ( S. pyogenes ) cell envelope proteinase A (cepA) gene antisense strand; and a reverse template comprising a nucleotide sequence comprising a recognition region at the 3′ end that is complementary to the 3′ end of the S. pyogenes cepA gene sense strand, wherein the forward template recognition region is 8-30 nucleotides in length and the reverse template recognition region is 8-30 nucleotides in length.
49 . The composition of claim 48 , wherein the forward template further comprises a nicking enzyme binding site and a nicking site upstream of the forward template recognition region; and comprises a stabilizing region upstream of the nicking site.
50 . The composition of claim 48 , wherein the reverse template further comprises a nicking enzyme binding site and a nicking site upstream the reverse template recognition region; and comprises a stabilizing region upstream of the nicking site.
51 . The composition of claim 48 , further comprising a probe oligonucleotide comprising a sequence complementary to the S. pyogenes cepA gene nucleotide sequence.
52 . The composition of claim 48 , further comprising a DNA polymerase; a nicking enzyme; and dNTPs or a mixture of dNTPs and ddNTPs.
53 . The composition of claim 48 , wherein the composition is lyophilized.
54 . The composition of claim 48 , wherein the forward template and/or the reverse template comprises a modified nucleotide, a spacer, or a blocking group.
55 . The composition of claim 48 , wherein the forward template and/or the reverse template comprises a modified nucleotide comprising a 2′ modification.
56 . The composition of claim 48 , wherein the forward template and/or the reverse template comprises a modified nucleotide comprising a 2′-O-methyl.
57 . The composition of claim 48 , wherein the forward template and/or the reverse template comprises a phosphorothioate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.